European Commission 10 July 2019, Non-opposition to a notified concentration (Case M.9274 — GlaxoSmithKline/Pfizer Consumer Healthcare Business) (Text with EEA relevance) 2020/C 15/02
Also known as
European Union · · · Cited by 1 · 16-01-2020
16.1.2020 EN Official Journal of the European Union C 15/2 Non-opposition to a notified concentration (Case M.9274 — GlaxoSmithKline/Pfizer Consumer Healthcare Business) (Text with EEA relevance) (2020/C 15/02) On 10 July 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market.
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (1 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit